肝移植后复发肝细胞癌的不典型表现。

IF 0.7 4区 医学 Q4 TRANSPLANTATION
Shiva Kumar
{"title":"肝移植后复发肝细胞癌的不典型表现。","authors":"Shiva Kumar","doi":"10.6002/ect.2025.0024","DOIUrl":null,"url":null,"abstract":"<p><p>Liver transplantation remains the optimal treatment modality for patients with early-stage hepatocellular carcinoma who meet criteria for transplant. With continued expansion of criteria for liver transplantation in hepatocellular carcinoma, tumor recurrence after transplant remains a major concern, with lung and bones being the most common sites of extrahepatic recurrence after liver transplant. Cardiac metastasis of hepatocellular carcinoma that is not contiguous with the primary liver lesion is extremely rare. We describe the first reported case of recurrent hepatocellular carcinoma after transplant presenting with left atrial cardiac metastasis. As was the case in our patient, prognosis of hepatocellular carcinoma with cardiac metastases is poor. This rare manifestation of advanced hepatocellular carcinoma should be considered in the differential diagnosis of patients with recurrent hepatocellular carcinoma after transplant presenting with cardiac symptoms or imaging evidence of left atrial soft tissue mass. This observation is of added relevance in the context of ongoing efforts to expand access to liver transplant for patients with hepatocellular carcinoma using immunotherapy to downstage tumors that exceed conventional criteria.</p>","PeriodicalId":50467,"journal":{"name":"Experimental and Clinical Transplantation","volume":"23 7","pages":"498-500"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Atypical Presentation of Recurrent Hepatocellular Carcinoma After Liver Transplant.\",\"authors\":\"Shiva Kumar\",\"doi\":\"10.6002/ect.2025.0024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Liver transplantation remains the optimal treatment modality for patients with early-stage hepatocellular carcinoma who meet criteria for transplant. With continued expansion of criteria for liver transplantation in hepatocellular carcinoma, tumor recurrence after transplant remains a major concern, with lung and bones being the most common sites of extrahepatic recurrence after liver transplant. Cardiac metastasis of hepatocellular carcinoma that is not contiguous with the primary liver lesion is extremely rare. We describe the first reported case of recurrent hepatocellular carcinoma after transplant presenting with left atrial cardiac metastasis. As was the case in our patient, prognosis of hepatocellular carcinoma with cardiac metastases is poor. This rare manifestation of advanced hepatocellular carcinoma should be considered in the differential diagnosis of patients with recurrent hepatocellular carcinoma after transplant presenting with cardiac symptoms or imaging evidence of left atrial soft tissue mass. This observation is of added relevance in the context of ongoing efforts to expand access to liver transplant for patients with hepatocellular carcinoma using immunotherapy to downstage tumors that exceed conventional criteria.</p>\",\"PeriodicalId\":50467,\"journal\":{\"name\":\"Experimental and Clinical Transplantation\",\"volume\":\"23 7\",\"pages\":\"498-500\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and Clinical Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.6002/ect.2025.0024\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"TRANSPLANTATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6002/ect.2025.0024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

摘要

肝移植仍然是满足移植标准的早期肝癌患者的最佳治疗方式。随着肝细胞癌肝移植标准的不断扩大,移植后肿瘤复发仍然是一个主要问题,肺和骨是肝移植后肝外复发最常见的部位。肝细胞癌的心脏转移不与原发肝脏病变相邻是非常罕见的。我们报告了首例肝细胞癌移植后复发并伴有左心房心脏转移的病例。与我们的病例一样,肝细胞癌合并心脏转移的预后很差。这种罕见的晚期肝细胞癌的表现应在移植后复发的肝细胞癌患者的鉴别诊断中加以考虑,这些患者有心脏症状或左心房软组织肿块的影像学证据。这一观察结果与目前正在努力扩大肝细胞癌患者接受肝移植的机会有关,肝细胞癌患者使用免疫疗法来降低超出常规标准的肿瘤的分期。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Atypical Presentation of Recurrent Hepatocellular Carcinoma After Liver Transplant.

Liver transplantation remains the optimal treatment modality for patients with early-stage hepatocellular carcinoma who meet criteria for transplant. With continued expansion of criteria for liver transplantation in hepatocellular carcinoma, tumor recurrence after transplant remains a major concern, with lung and bones being the most common sites of extrahepatic recurrence after liver transplant. Cardiac metastasis of hepatocellular carcinoma that is not contiguous with the primary liver lesion is extremely rare. We describe the first reported case of recurrent hepatocellular carcinoma after transplant presenting with left atrial cardiac metastasis. As was the case in our patient, prognosis of hepatocellular carcinoma with cardiac metastases is poor. This rare manifestation of advanced hepatocellular carcinoma should be considered in the differential diagnosis of patients with recurrent hepatocellular carcinoma after transplant presenting with cardiac symptoms or imaging evidence of left atrial soft tissue mass. This observation is of added relevance in the context of ongoing efforts to expand access to liver transplant for patients with hepatocellular carcinoma using immunotherapy to downstage tumors that exceed conventional criteria.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.40
自引率
11.10%
发文量
258
审稿时长
6-12 weeks
期刊介绍: The scope of the journal includes the following: Surgical techniques, innovations, and novelties; Immunobiology and immunosuppression; Clinical results; Complications; Infection; Malignancies; Organ donation; Organ and tissue procurement and preservation; Sociological and ethical issues; Xenotransplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信